IL-2Rα模拟肽的筛选及其抑制小鼠皮肤移植排斥反应的研究
发布时间:2018-06-22 03:27
本文选题:噬菌体展示 + IL-2Rα ; 参考:《吉林大学》2007年博士论文
【摘要】: 免疫抑制剂在器官移植排斥反应的预防和治疗中起到了关键作用,人们认为最佳的免疫抑制剂至少应达到三个目标:选择性、协同性和特异性。但是,当前临床应用的免疫抑制剂只是部分地满足这些目标。为研制新型的肽类免疫抑制剂,我们以抗人IL-2Rα单克隆抗体5G1为靶分子,对噬菌体环七肽库进行了5轮筛选,经鉴定获得了5个与靶分子具有高亲和力的噬菌体阳性克隆,通过对其DNA序列进行分析,得到IL-2Rα模拟表位肽的氨基酸保守序列: Lys-X-{X}-Lys-Gly。应用化学合成法制备环七肽CP,其氨基酸序列为:Cys-Asn-Ala-Leu- Lys-Arg-Lys-Gly-Cys,相对分子量为990.2。经检测证实CP对正常小鼠脾细胞没有毒性。计算机模拟证实CP与人IL-2的功能活性部位可形成稳定、良好的结合。经淋巴细胞周期测定、淋巴细胞增殖反应、迟发型超敏反应和局部移植物抗宿主反应等多项体内外的实验证实:环七肽CP具有较强的免疫抑制活性,其与环孢菌素A联用抑制效应明显增强,显示二者具有协同效应。环七肽CP可有效地抑制小鼠异基因皮肤移植排斥反应,诱导出宿主对皮肤移植物的耐受;实验证实克隆不应答、减少宿主体内CD4+ T淋巴细胞的数目和抑制其功能、Th1型细胞因子偏移的纠正等机制参与了移植耐受的形成。以上的实验结果表明:环七肽CP以IL-2Rα模拟肽的方式发挥生物学效应,本研究为将其研制成一种高效、低毒、特异性强的小分子肽类免疫抑制剂奠定了基础。
[Abstract]:Immunosuppressants play a key role in the prevention and treatment of organ transplantation rejection. It is considered that the best immunosuppressant should achieve at least three goals: selectivity, synergy and specificity. However, the current clinical use of immunosuppressants only partially meets these goals. In order to develop a novel peptide immunosuppressant, we used 5G1 monoclonal antibody against human IL-2R 伪 as target molecule to screen phage cyclopeptide library for five rounds. Five phage positive clones with high affinity to target molecule were obtained. The amino acid conserved sequence of IL-2R 伪 mimic epitope peptide was obtained by analyzing its DNA sequence: Lys-X- {X} -Lys-Gly. The cyclic heptapeptide CPS was prepared by chemical synthesis. Its amino acid sequence was: 1 Cys-Asn-Ala-Leu-Lys-Arg-Lys-Gly-Cys-Gly-Cys. the relative molecular weight was 990.2. CP is not toxic to spleen cells of normal mice. It was proved by computer simulation that the functional active sites of CP and IL-2 could form stable and good binding. Lymphocyte cycle assay, lymphocyte proliferation, delayed type hypersensitivity and local graft versus host reaction in vivo and in vitro confirmed that cyclopeptide CP had strong immunosuppressive activity. The inhibitory effect of cyclosporine A combined with cyclosporine A was significantly enhanced, indicating that the two had synergistic effect. Cyclopeptide CP can effectively inhibit allogeneic skin graft rejection in mice and induce host tolerance to skin grafts. The mechanism of decreasing the number of CD4 T lymphocytes and inhibiting the correction of Th1 type cytokine shift in host is involved in the formation of transplantation tolerance. The above results show that cyclic heptapeptide CP exerts biological effect on IL-2R 伪 mimic peptide. This study has laid a foundation for the development of a small molecular peptide immunosuppressant with high efficiency, low toxicity and strong specificity.
【学位授予单位】:吉林大学
【学位级别】:博士
【学位授予年份】:2007
【分类号】:R392.33
【参考文献】
相关期刊论文 前10条
1 杨宣斌,熊方武;抗肾移植排斥药Basiliximab[J];国外医药(合成药 生化药 制剂分册);2000年01期
2 朱迅;田志刚;杨贵贞;;白细胞介素2受体(IL-2R)——单克隆抗体特性及临床应用前景[J];国外医学(免疫学分册);1988年04期
3 孙尔维,张雷;一种新型免疫抑制剂—FTY720[J];国外医学(免疫学分册);2000年01期
4 孙淑娟,李宏建,谷大建,苏乐群,牟燕;新型免疫抑制剂Tacrolimus的药理及临床应用[J];中国临床药学杂志;1998年05期
5 徐红冰,寿佳慧,归成,陶亚菊,李灿明;霉酚酸酯在肾移植患者中的应用[J];中国临床药学杂志;2001年03期
6 文维延,韩强涛,富宁;脂多糖保守表位模拟肽的筛选与鉴定[J];生物化学与生物物理进展;2001年02期
7 曹晓芝,孙成春,王景祥;68例肾移植病人用环孢素及硫唑嘌呤出现肝损害[J];新药与临床;1997年04期
8 陈春霞,秦建华,余伟均;鼻用胰岛素气雾剂的实验研究[J];中国药理学通报;1997年06期
9 瞿文,陈庆华,赵瑞钦,李宁,周美华;丙氨瑞林生物可降解缓释微球注射剂的研究[J];中国医药工业杂志;2000年01期
10 敖建华,肖序仁,李炎唐,卢锦山,王晓雄;肾移植术后应用他克莫司的临床观察[J];中华器官移植杂志;2000年03期
,本文编号:2051367
本文链接:https://www.wllwen.com/yixuelunwen/binglixuelunwen/2051367.html
最近更新
教材专著